In the future, this presents new opportunities for the investigation of prospective diagnostic and therapeutic targets for NAFLD. Non-alcoholic fatty liver disease (NAFLD) has emerged as the most ...
Microbiome Changes in Chronic Liver Disease Highlight the Need for Personalized ... pivotal role in defending against gut bacteria and related substances entering via the portal vein, particularly ...
Alcohol-related liver disease (ARLD) is a serious health problem that can develop when the liver is repeatedly exposed to excessive alcohol. The liver, a vital organ responsible for detoxifying the ...
alfapump® is the first US approved active implantable medical device (Class III) for the treatment of recurrent or refractory ascites due to liver cirrhosis US market opportunity estimated at over $2 ...
In May, nearly 29,000 patients picked up the pills from retail pharmacies in the United States, the FDA said.The FDA first warned in September that the drug could cause liver problems. It ...
To produce liver cirrhosis, 1% DMN dissolved in saline was given intraperitoneally at 1 ml per kg body weight for 3 consecutive days per week for 4–6 weeks as described 12. The expression vector ...